A Real-World Evidence Study on U.S. Patients Demonstrating Safety of High-Frequency Use of the Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment - Takeaways - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
A Real-World Evidence Study on U.S. Patients Demonstrating Safety of High-Frequency Use of the Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment
This real-world observational study evaluates the safety and tolerability of remote electrical neuromodulation (REN; Nerivio®) in patients who have utilized it more frequently than the current label indication for migraine treatment.
This real-world observational study assessed the safety and tolerability of REN use beyond current labeling for migraine treatment.
2
The study included data from 1,863 patients and more than 80,000 REN treatment sessions.
3
Evaluated use patterns included multiple treatments in 1 day and daily treatment.
4
Device-related adverse events occurred in fewer than 1% of patients and were negligible to moderate in severity.
5
Reported events resolved without medical intervention; no serious device-related adverse events were reported, and most patients continued therapy after an event.
